NVAX•benzinga•
FDA Delays Full Approval Decision On Novavax's COVID-19 Vaccine (UPDATED)
Summary
Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 3, 2025 by benzinga